Gossamer Bio, Inc.
GOSS
$3.42
$0.4314.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.55% | -177.74% | 12.62% | 31.40% | 23.01% |
| Total Depreciation and Amortization | -79.96% | -78.53% | -65.31% | 6.86% | 0.92% |
| Total Amortization of Deferred Charges | 5.98% | -23.68% | -17.75% | -22.73% | -27.55% |
| Total Other Non-Cash Items | 474.68% | -68.03% | -108.51% | -85.65% | -63.02% |
| Change in Net Operating Assets | 174.77% | -115.50% | 76.88% | -678.23% | -5,361.04% |
| Cash from Operations | -12.91% | -140.45% | 24.05% | -6.15% | 7.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 163.59% | 174.74% | -64.19% | 470.43% | 77.38% |
| Cash from Investing | 163.59% | 174.65% | -64.23% | 470.43% | 77.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 566.19% | -- | 44.83% | -- | -99.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 566.19% | 101.02% | 119.73% | 100.00% | -99.86% |
| Foreign Exchange rate Adjustments | -202.15% | 1,712.50% | 269.35% | -164.77% | 168.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.25% | -105.65% | -352.49% | 134.87% | -228.08% |